Know Cancer

or
forgot password

Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry


N/A
18 Years
N/A
Open (Enrolling)
Both
Myeloproliferative Disorders, Myeloproliferative Disorders (MPD)

Thank you

Trial Information

Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry


Inclusion Criteria:

Any patient who carries a diagnosis of a myeloproliferative disorder
(MPD).

Exclusion Criteria:Any patient who is not willing to give consent.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Jason Robert Gotlib

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

SU-07092009-3060

NCT ID:

NCT01144780

Start Date:

September 2009

Completion Date:

August 2011

Related Keywords:

  • Myeloproliferative Disorders
  • Myeloproliferative Disorders (MPD)
  • Myeloproliferative Disorders

Name

Location

Stanford University School of MedicineStanford, California  94305-5317